Shandong Boan Biotechnology Co., Ltd. (“Boan Biotech”, stock code: 06955.HK) announced the placement arrangement for the issuance of 26,655,600 new H shares on August 7, 2024, which was successfully completed recently.

As the PRC legal counsel to the underwriter, Jingtian & Gongcheng participated in the whole new H-share placement.